Dolutegravir + lamivudine (Dovato)
- Status:
- Red
- Decision Date:
- September 2019
Comments
RED: Treatment of HIV-1 infection in adults and adolescents aged>12 years
weighing ≥40kg, with no known or suspected resistance to the integrase
inhibitor class, or lamivudine. Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again